ArticleNPJ precision oncology2025

Integrative analysis of KEAP1/NFE2L2 alterations across 3600+ tumors reveals an NRF2 expression signature as a prognostic biomarker in cancer.

Valentina Crippa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.